S. Bachmayer

发表

Metabolic dysfunction-associated fatty liver disease (MAFLD) - rather a bystander than a driver of mortality.

D. Niederseer, C. Datz, M. Egger, 2021, The Journal of clinical endocrinology and metabolism.

Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease

U. Huber-Schönauer, D. Niederseer, C. Datz, 2020, PloS one.

Atrial Fibrillation: A New Indicator for Advanced Colorectal Neoplasia in Screening Colonoscopy

U. Huber-Schönauer, D. Niederseer, C. Datz, 2018, Journal of clinical medicine.

Determination of ionic species formed during growth of Escherichia coli by capillary isotachophoresis.

M. Ammann, E. Kenndler, K. Futschik, 1993, Journal of chromatography.

Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk—A Single-Center Cross-Sectional Study

U. Huber-Schönauer, D. Niederseer, C. Datz, 2021, Clinical and translational gastroenterology.

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) Is Independently Associated with Cardiovascular Risk in a Large Austrian Screening Cohort

U. Huber-Schönauer, D. Niederseer, C. Datz, 2020, Journal of clinical medicine.

Machine Learning Models Cannot Replace Screening Colonoscopy for the Prediction of Advanced Colorectal Adenoma

C. Datz, V. Osmani, B. Wernly, 2021, Journal of personalized medicine.

A sex-specific propensity-adjusted analysis of colonic adenoma detection rates in a screening cohort

U. Huber-Schönauer, D. Niederseer, C. Datz, 2021, Scientific Reports.

Nonmetastatic pancreatic cancer

R. Greil, F. Sedlmayer, G. Rinnerthaler, 2018, Strahlentherapie und Onkologie.